• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在临床和社区人群中,丁酰胆碱酯酶基因与晚发型阿尔茨海默病既无独立关联也无协同关联。

The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations.

作者信息

Crawford F, Fallin D, Suo Z, Abdullah L, Gold M, Gauntlett A, Duara R, Mullan M

机构信息

Roskamp Laboratories, University of South Florida, Tampa 33613, USA.

出版信息

Neurosci Lett. 1998 Jun 19;249(2-3):115-8. doi: 10.1016/s0304-3940(98)00423-6.

DOI:10.1016/s0304-3940(98)00423-6
PMID:9682830
Abstract

The K variant of the butyrylcholinesterase gene (BChE) was recently found to occur at an increased frequency in a late onset Alzheimer's disease (AD) population, specifically in individuals carrying the epsilon4 allele of the apolipoprotein E (APOE) gene. This suggested synergy between these two genes resulting in an increased risk of late-onset AD. We have genotyped 62 community-based and 329 clinic-based AD cases, and 201 community-based controls at BChE and APOE and find no independent association between BChE and AD nor interaction with APOE in risk for AD in either our clinic or community-based samples.

摘要

最近发现,丁酰胆碱酯酶基因(BChE)的K变体在晚发性阿尔茨海默病(AD)人群中出现的频率增加,特别是在携带载脂蛋白E(APOE)基因ε4等位基因的个体中。这表明这两个基因之间存在协同作用,导致晚发性AD风险增加。我们对62例社区AD病例、329例临床AD病例以及201例社区对照进行了BChE和APOE基因分型,发现在我们的临床样本或社区样本中,BChE与AD之间不存在独立关联,在AD风险方面也不存在与APOE的相互作用。

相似文献

1
The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations.在临床和社区人群中,丁酰胆碱酯酶基因与晚发型阿尔茨海默病既无独立关联也无协同关联。
Neurosci Lett. 1998 Jun 19;249(2-3):115-8. doi: 10.1016/s0304-3940(98)00423-6.
2
No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.丁酰胆碱酯酶K变体基因与载脂蛋白E4在晚发性阿尔茨海默病中无关联。
Am J Med Genet. 1999 Apr 16;88(2):113-5. doi: 10.1002/(sici)1096-8628(19990416)88:2<113::aid-ajmg2>3.0.co;2-3.
3
Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.丁酰胆碱酯酶K变体基因与载脂蛋白E4在晚发型确诊阿尔茨海默病中的协同作用。
Hum Mol Genet. 1997 Oct;6(11):1933-6. doi: 10.1093/hmg/6.11.1933.
4
Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.二肽基羧肽酶1(DCP1)和丁酰胆碱酯酶(BCHE)基因与载脂蛋白Eε4等位基因的相互作用,作为阿尔茨海默病以及伴有阿尔茨海默病理共存的帕金森病的风险因素。
J Med Genet. 2000 Oct;37(10):766-70. doi: 10.1136/jmg.37.10.766.
5
Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.在确诊的阿尔茨海默病中,APOE ε4与丁酰胆碱酯酶-K之间存在协同关联的进一步证据。
Hum Genet. 1999 Feb;104(2):158-63. doi: 10.1007/s004390050929.
6
Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients.丁酰胆碱酯酶K变体和载脂蛋白E4基因在芬兰晚发性阿尔茨海默病患者中不存在协同作用。
Neurosci Lett. 1998 Jun 26;250(1):69-71. doi: 10.1016/s0304-3940(98)00453-4.
7
Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease.在日本阿尔茨海默病患者中未能证实丁酰胆碱酯酶基因的K-变体与载脂蛋白基因的ε4等位基因之间存在协同效应。
J Neurol Neurosurg Psychiatry. 1999 Jul;67(1):94-6. doi: 10.1136/jnnp.67.1.94.
8
Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.丁酰胆碱酯酶K变体在基因上与北爱尔兰晚发性阿尔茨海默病相关。
J Med Genet. 2000 Mar;37(3):182-5. doi: 10.1136/jmg.37.3.182.
9
The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.丁酰胆碱酯酶K变体与阿尔茨海默病易感性
J Med Genet. 1998 Dec;35(12):1034-5. doi: 10.1136/jmg.35.12.1034.
10
Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.阿尔茨海默病中丁酰胆碱酯酶K变异体与载脂蛋白E基因型之间的关联分析。
Neurosci Lett. 2004 Nov 23;371(2-3):142-6. doi: 10.1016/j.neulet.2004.08.057.

引用本文的文献

1
Confirmed Synergy Between the ɛ4 Allele of Apolipoprotein E and the Variant K of Butyrylcholinesterase as a Risk Factor for Alzheimer's Disease: A Systematic Review and Meta-Analysis.载脂蛋白E的ɛ4等位基因与丁酰胆碱酯酶变体K之间的协同作用被确认为阿尔茨海默病的一个风险因素:一项系统评价和荟萃分析。
J Alzheimers Dis Rep. 2023 Jun 19;7(1):613-625. doi: 10.3233/ADR-220084. eCollection 2023.
2
Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.丁酰胆碱酯酶 K 变异体 N 端区域的改变与载脂蛋白 E4 在晚发性阿尔茨海默病中的协同作用。
Sci Rep. 2019 Mar 26;9(1):5223. doi: 10.1038/s41598-019-41578-3.
3
Association of and with Alzheimer's disease: Meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls.
[基因名称1]和[基因名称2]与阿尔茨海默病的关联:基于对12563例病例和12622例对照的56项基因病例对照研究的荟萃分析。
Exp Ther Med. 2015 May;9(5):1831-1840. doi: 10.3892/etm.2015.2327. Epub 2015 Mar 3.
4
Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis.丁酰胆碱酯酶K变异体与阿尔茨海默病风险:一项荟萃分析。
Med Sci Monit. 2015 May 16;21:1408-13. doi: 10.12659/MSM.892982.
5
A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.丁酰胆碱酯酶作为阿尔茨海默病治疗靶点的综述。
Prim Care Companion CNS Disord. 2013;15(2). doi: 10.4088/PCC.12r01412. Epub 2013 Mar 7.
6
GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.GAB2基因不会改变西班牙APOE 4携带者患阿尔茨海默病的风险。
J Nutr Health Aging. 2009 Mar;13(3):214-9. doi: 10.1007/s12603-009-0061-6.
7
Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.二肽基羧肽酶1(DCP1)和丁酰胆碱酯酶(BCHE)基因与载脂蛋白Eε4等位基因的相互作用,作为阿尔茨海默病以及伴有阿尔茨海默病理共存的帕金森病的风险因素。
J Med Genet. 2000 Oct;37(10):766-70. doi: 10.1136/jmg.37.10.766.
8
Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.丁酰胆碱酯酶K变体在基因上与北爱尔兰晚发性阿尔茨海默病相关。
J Med Genet. 2000 Mar;37(3):182-5. doi: 10.1136/jmg.37.3.182.